Search Results - "Sihto, Harri"
-
1
Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy
Published in Scientific reports (17-02-2021)“…The treatment of patients with ERBB2 (HER2)-positive breast cancer with anti- ERBB2 therapy is based on the detection of ERBB2 gene amplification or protein…”
Get full text
Journal Article -
2
UV-induced local immunosuppression in the tumour microenvironment of eccrine porocarcinoma and poroma
Published in Scientific reports (01-04-2022)“…Eccrine porocarcinoma (EPC) is a rare malignant adnexal tumour of the skin. Part of EPCs develop from their benign counterpart, poroma (EP), with chronic light…”
Get full text
Journal Article -
3
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Published in Nature communications (06-02-2019)“…Elevated MYC expression sensitizes tumor cells to apoptosis but the therapeutic potential of this mechanism remains unclear. We find, in a model of MYC-driven…”
Get full text
Journal Article -
4
L-type calcium channels regulate filopodia stability and cancer cell invasion downstream of integrin signalling
Published in Nature communications (02-12-2016)“…Mounting in vitro , in vivo and clinical evidence suggest an important role for filopodia in driving cancer cell invasion. Using a high-throughput…”
Get full text
Journal Article -
5
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
Published in Nature communications (28-05-2019)“…The human epidermal growth factor receptor 2 (HER2) is an oncogene targeted by several kinase inhibitors and therapeutic antibodies. While the endosomal…”
Get full text
Journal Article -
6
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial
Published in Journal of clinical oncology (20-01-2016)“…Three years of adjuvant imatinib therapy are recommended for patients with GI stromal tumor (GIST) with high-risk features, according to survival findings in…”
Get full text
Journal Article -
7
LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
Published in Virchows Archiv : an international journal of pathology (01-12-2021)“…Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine malignancy of the skin. The cell of origin of MCC is thus far unknown and proposed cells of…”
Get full text
Journal Article -
8
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses
Published in International journal of cancer (15-05-2023)“…Merkel cell carcinoma (MCC) is a cutaneous neuroendocrine malignancy with a poor prognosis and an unknown cell of origin. Proffered cells of origin include…”
Get full text
Journal Article -
9
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription
Published in Nature communications (04-08-2016)“…Tissue homeostasis is dependent on the controlled localization of specific cell types and the correct composition of the extracellular stroma. While the role…”
Get full text
Journal Article -
10
Neurocan expression associates with better survival and viral positivity in Merkel cell carcinoma
Published in PloS one (05-05-2023)“…Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine carcinoma that is frequently divided into Merkel cell polyomavirus negative and positive tumors…”
Get full text
Journal Article -
11
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
Published in PloS one (24-05-2021)“…Merkel cell carcinoma (MCC) is a rare skin cancer with only limited therapeutic options for advanced disease. We previously showed that oncogene ALK is…”
Get full text
Journal Article -
12
Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study
Published in Clinical cancer research (15-05-2012)“…Merkel cell carcinoma (MCC) is a rare skin cancer that often harbors Merkel cell polyomavirus (MCPyV) DNA. The clinical importance of intratumoral immune cells…”
Get full text
Journal Article -
13
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis
Published in The Journal of clinical investigation (01-03-2014)“…Mutations of the tumor suppressor TP53 are present in many forms of human cancer and are associated with increased tumor cell invasion and metastasis. Several…”
Get full text
Journal Article -
14
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
Published in Breast cancer research : BCR (13-09-2011)“…Some molecular subtypes of breast cancer have preferential sites of distant relapse. The protein expression pattern of the primary tumor may influence the…”
Get full text
Journal Article -
15
Eccrine Porocarcinoma: Clinical and Histopathological Study of 14 Patients with Special Emphasis on Sentinel Lymph Node Biopsy
Published in Acta dermato-venereologica (13-07-2023)“…Eccrine porocarcinoma is a rare skin adnexal tumour that affects elderly people. Most eccrine porocarcinomas are stage I or II according to the American Joint…”
Get full text
Journal Article -
16
Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization
Published in EMBO molecular medicine (01-06-2019)“…The current clinical care of glioblastomas leaves behind invasive, radio‐ and chemo‐resistant cells. We recently identified mammary‐derived growth inhibitor…”
Get full text
Journal Article -
17
The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma
Published in International journal of molecular sciences (28-03-2022)“…Merkel cell polyomavirus (MCPyV) is a causal factor in Merkel cell carcinoma (MCC). The oncogenic potential is mediated through its viral oncoproteins large…”
Get full text
Journal Article -
18
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment
Published in PloS one (16-02-2018)“…Despite of multitude investigations no reliable prognostic immunohistochemical biomarkers in GIST have been established so far with added value to predict the…”
Get full text
Journal Article -
19
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1
Published in Cancer discovery (01-02-2013)“…Senescence induction contributes to cancer therapy responses and is crucial for p53-mediated tumor suppression. However, whether p53 inactivation actively…”
Get more information
Journal Article -
20
Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy
Published in Nature communications (20-02-2019)“…The original version of this Article contained an error in Fig. 7. In panel b, the survival curves were shifted relative to the y axis. This error has been…”
Get full text
Journal Article